The PSI 2023 Conference took place at Novotel Hammersmith, London between the 11th and 14th of June 2023.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with a choice from two optional half day training course on the Sunday afternoon.
The 2023 PSI conference was record-breaking all round, with 618 delegates listening to more than 120 speakers across 40 sessions! Thank you to everyone involved in the conference: speakers, poster presenters, delegates, exhibitors, sponsors and the PSI scientific committee, for contributing to another fantastic event.
David Lawrence, 2023 PSI Conference Chair
Sarah Williams, 2023 PSI Conference Vice-Chair
Kate Taylor, 2023 PSI Conference Vice-Chair
To access the recorded sessions from the PSI 2023 Conference, please visit our Video on Demand homepage.
To source the Conference content, simply select 'PSI 2023 Conference' from the 'Collection' dropdown menu. This will filter all available content to only show on-demand sessions from the 2023 Conference.
Please note: these are only available to view for Members of PSI, and will need to be signed in to watch them.
A select few of this year's sessions only have the slide decks available. Please see Session Titles listed below, with slide decks available to download beneath.
Please note: these are only accessible for Members of PSI, and you will need to be signed in to access them.
Interactive workshop on communicating data to Data Monitoring Committees
In this interactive workshop, we focused on communicating data to a DMC. The goal of the session was to illustrate difficulties a DMC may have with a report that is not fit for purpose and discuss suggestions for improvements to DMC reports including newer technologies such as apps facilitating an in-depth interrogation of the data. Due to the interactive nature of this session, we wanted to share the slides with members for recapping the session.
HTA & Launch & Life Cycle SIG: Connecting the dots: how can statisticians drive end-to-end thinking in the development of new medicines?
The session began with a lightning round of 5-minute talks from statisticians with different specializations across the lifecycle. These short presentations, where presenters clarify their roles, set the scene. Participants who joined the session then broke out and discussed case studies of “typical new products” intended to help identify and understand the challenges for statisticians from the different perspectives of regulatory, HTA, and medical affairs.
Learning from Mistakes
Experience is the name we give to our mistakes” (Oscar Wilde). Every child falls over before they learn to walk and yet in the workplace there remains fear of making an error. As statisticians, we all understand that even the most stringent processes have a failure rate, but despite this, we often demand perfection from ourselves. Mistakes can range from the trivial through to ones that cost a great deal in time and money. Experienced pharmaceutical statisticians will share some mistakes made and more importantly how to find solutions and share the lessons learnt. Our careers grow from how we respond to problems and challenges. This growth is only possible if organisations create a culture where employees can openly share mistakes and raise concerns; good managers create a healthy environment for staff to thrive and develop, and understand that fear of failure and stress are barriers to progress.
Adaptive Designs - What, why, when and how should I use them
Adaptive designs offer many potential benefits throughout the clinical development process. However, not all of these benefits are accessible all of the time. One must use the right trial design in the right context, which requires careful reflection on the trial’s aim. The intuition about when to use which method presents a barrier to implementation in practice with much of the knowledge locked within the community already practising adaptive designs. In this session, we presented a series of examples and quizzes to help the audience develop their own intuition for adaptive designs. We focussed in particular on group sequential designs that offer the opportunity for early stopping, adaptive designs involving multiple hypothesis tests such as enrichment designs and seamless phase 2-3 designs, and designs that incorporate response adaptive randomisation.
The PSI 2023 Conference took place at Novotel Hammersmith, London between the 11th and 14th of June 2023.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with a choice from two optional half day training course on the Sunday afternoon.
The 2023 PSI conference was record-breaking all round, with 618 delegates listening to more than 120 speakers across 40 sessions! Thank you to everyone involved in the conference: speakers, poster presenters, delegates, exhibitors, sponsors and the PSI scientific committee, for contributing to another fantastic event.
David Lawrence, 2023 PSI Conference Chair
Sarah Williams, 2023 PSI Conference Vice-Chair
Kate Taylor, 2023 PSI Conference Vice-Chair
To access the recorded sessions from the PSI 2023 Conference, please visit our Video on Demand homepage.
To source the Conference content, simply select 'PSI 2023 Conference' from the 'Collection' dropdown menu. This will filter all available content to only show on-demand sessions from the 2023 Conference.
Please note: these are only available to view for Members of PSI, and will need to be signed in to watch them.
A select few of this year's sessions only have the slide decks available. Please see Session Titles listed below, with slide decks available to download beneath.
Please note: these are only accessible for Members of PSI, and you will need to be signed in to access them.
Interactive workshop on communicating data to Data Monitoring Committees
In this interactive workshop, we focused on communicating data to a DMC. The goal of the session was to illustrate difficulties a DMC may have with a report that is not fit for purpose and discuss suggestions for improvements to DMC reports including newer technologies such as apps facilitating an in-depth interrogation of the data. Due to the interactive nature of this session, we wanted to share the slides with members for recapping the session.
HTA & Launch & Life Cycle SIG: Connecting the dots: how can statisticians drive end-to-end thinking in the development of new medicines?
The session began with a lightning round of 5-minute talks from statisticians with different specializations across the lifecycle. These short presentations, where presenters clarify their roles, set the scene. Participants who joined the session then broke out and discussed case studies of “typical new products” intended to help identify and understand the challenges for statisticians from the different perspectives of regulatory, HTA, and medical affairs.
Learning from Mistakes
Experience is the name we give to our mistakes” (Oscar Wilde). Every child falls over before they learn to walk and yet in the workplace there remains fear of making an error. As statisticians, we all understand that even the most stringent processes have a failure rate, but despite this, we often demand perfection from ourselves. Mistakes can range from the trivial through to ones that cost a great deal in time and money. Experienced pharmaceutical statisticians will share some mistakes made and more importantly how to find solutions and share the lessons learnt. Our careers grow from how we respond to problems and challenges. This growth is only possible if organisations create a culture where employees can openly share mistakes and raise concerns; good managers create a healthy environment for staff to thrive and develop, and understand that fear of failure and stress are barriers to progress.
Adaptive Designs - What, why, when and how should I use them
Adaptive designs offer many potential benefits throughout the clinical development process. However, not all of these benefits are accessible all of the time. One must use the right trial design in the right context, which requires careful reflection on the trial’s aim. The intuition about when to use which method presents a barrier to implementation in practice with much of the knowledge locked within the community already practising adaptive designs. In this session, we presented a series of examples and quizzes to help the audience develop their own intuition for adaptive designs. We focussed in particular on group sequential designs that offer the opportunity for early stopping, adaptive designs involving multiple hypothesis tests such as enrichment designs and seamless phase 2-3 designs, and designs that incorporate response adaptive randomisation.
The PSI 2023 Conference took place at Novotel Hammersmith, London between the 11th and 14th of June 2023.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with a choice from two optional half day training course on the Sunday afternoon.
The 2023 PSI conference was record-breaking all round, with 618 delegates listening to more than 120 speakers across 40 sessions! Thank you to everyone involved in the conference: speakers, poster presenters, delegates, exhibitors, sponsors and the PSI scientific committee, for contributing to another fantastic event.
David Lawrence, 2023 PSI Conference Chair
Sarah Williams, 2023 PSI Conference Vice-Chair
Kate Taylor, 2023 PSI Conference Vice-Chair
To access the recorded sessions from the PSI 2023 Conference, please visit our Video on Demand homepage.
To source the Conference content, simply select 'PSI 2023 Conference' from the 'Collection' dropdown menu. This will filter all available content to only show on-demand sessions from the 2023 Conference.
Please note: these are only available to view for Members of PSI, and will need to be signed in to watch them.
A select few of this year's sessions only have the slide decks available. Please see Session Titles listed below, with slide decks available to download beneath.
Please note: these are only accessible for Members of PSI, and you will need to be signed in to access them.
Interactive workshop on communicating data to Data Monitoring Committees
In this interactive workshop, we focused on communicating data to a DMC. The goal of the session was to illustrate difficulties a DMC may have with a report that is not fit for purpose and discuss suggestions for improvements to DMC reports including newer technologies such as apps facilitating an in-depth interrogation of the data. Due to the interactive nature of this session, we wanted to share the slides with members for recapping the session.
HTA & Launch & Life Cycle SIG: Connecting the dots: how can statisticians drive end-to-end thinking in the development of new medicines?
The session began with a lightning round of 5-minute talks from statisticians with different specializations across the lifecycle. These short presentations, where presenters clarify their roles, set the scene. Participants who joined the session then broke out and discussed case studies of “typical new products” intended to help identify and understand the challenges for statisticians from the different perspectives of regulatory, HTA, and medical affairs.
Learning from Mistakes
Experience is the name we give to our mistakes” (Oscar Wilde). Every child falls over before they learn to walk and yet in the workplace there remains fear of making an error. As statisticians, we all understand that even the most stringent processes have a failure rate, but despite this, we often demand perfection from ourselves. Mistakes can range from the trivial through to ones that cost a great deal in time and money. Experienced pharmaceutical statisticians will share some mistakes made and more importantly how to find solutions and share the lessons learnt. Our careers grow from how we respond to problems and challenges. This growth is only possible if organisations create a culture where employees can openly share mistakes and raise concerns; good managers create a healthy environment for staff to thrive and develop, and understand that fear of failure and stress are barriers to progress.
Adaptive Designs - What, why, when and how should I use them
Adaptive designs offer many potential benefits throughout the clinical development process. However, not all of these benefits are accessible all of the time. One must use the right trial design in the right context, which requires careful reflection on the trial’s aim. The intuition about when to use which method presents a barrier to implementation in practice with much of the knowledge locked within the community already practising adaptive designs. In this session, we presented a series of examples and quizzes to help the audience develop their own intuition for adaptive designs. We focussed in particular on group sequential designs that offer the opportunity for early stopping, adaptive designs involving multiple hypothesis tests such as enrichment designs and seamless phase 2-3 designs, and designs that incorporate response adaptive randomisation.
The PSI 2023 Conference took place at Novotel Hammersmith, London between the 11th and 14th of June 2023.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with a choice from two optional half day training course on the Sunday afternoon.
The 2023 PSI conference was record-breaking all round, with 618 delegates listening to more than 120 speakers across 40 sessions! Thank you to everyone involved in the conference: speakers, poster presenters, delegates, exhibitors, sponsors and the PSI scientific committee, for contributing to another fantastic event.
David Lawrence, 2023 PSI Conference Chair
Sarah Williams, 2023 PSI Conference Vice-Chair
Kate Taylor, 2023 PSI Conference Vice-Chair
To access the recorded sessions from the PSI 2023 Conference, please visit our Video on Demand homepage.
To source the Conference content, simply select 'PSI 2023 Conference' from the 'Collection' dropdown menu. This will filter all available content to only show on-demand sessions from the 2023 Conference.
Please note: these are only available to view for Members of PSI, and will need to be signed in to watch them.
A select few of this year's sessions only have the slide decks available. Please see Session Titles listed below, with slide decks available to download beneath.
Please note: these are only accessible for Members of PSI, and you will need to be signed in to access them.
Interactive workshop on communicating data to Data Monitoring Committees
In this interactive workshop, we focused on communicating data to a DMC. The goal of the session was to illustrate difficulties a DMC may have with a report that is not fit for purpose and discuss suggestions for improvements to DMC reports including newer technologies such as apps facilitating an in-depth interrogation of the data. Due to the interactive nature of this session, we wanted to share the slides with members for recapping the session.
HTA & Launch & Life Cycle SIG: Connecting the dots: how can statisticians drive end-to-end thinking in the development of new medicines?
The session began with a lightning round of 5-minute talks from statisticians with different specializations across the lifecycle. These short presentations, where presenters clarify their roles, set the scene. Participants who joined the session then broke out and discussed case studies of “typical new products” intended to help identify and understand the challenges for statisticians from the different perspectives of regulatory, HTA, and medical affairs.
Learning from Mistakes
Experience is the name we give to our mistakes” (Oscar Wilde). Every child falls over before they learn to walk and yet in the workplace there remains fear of making an error. As statisticians, we all understand that even the most stringent processes have a failure rate, but despite this, we often demand perfection from ourselves. Mistakes can range from the trivial through to ones that cost a great deal in time and money. Experienced pharmaceutical statisticians will share some mistakes made and more importantly how to find solutions and share the lessons learnt. Our careers grow from how we respond to problems and challenges. This growth is only possible if organisations create a culture where employees can openly share mistakes and raise concerns; good managers create a healthy environment for staff to thrive and develop, and understand that fear of failure and stress are barriers to progress.
Adaptive Designs - What, why, when and how should I use them
Adaptive designs offer many potential benefits throughout the clinical development process. However, not all of these benefits are accessible all of the time. One must use the right trial design in the right context, which requires careful reflection on the trial’s aim. The intuition about when to use which method presents a barrier to implementation in practice with much of the knowledge locked within the community already practising adaptive designs. In this session, we presented a series of examples and quizzes to help the audience develop their own intuition for adaptive designs. We focussed in particular on group sequential designs that offer the opportunity for early stopping, adaptive designs involving multiple hypothesis tests such as enrichment designs and seamless phase 2-3 designs, and designs that incorporate response adaptive randomisation.
The PSI 2023 Conference took place at Novotel Hammersmith, London between the 11th and 14th of June 2023.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with a choice from two optional half day training course on the Sunday afternoon.
The 2023 PSI conference was record-breaking all round, with 618 delegates listening to more than 120 speakers across 40 sessions! Thank you to everyone involved in the conference: speakers, poster presenters, delegates, exhibitors, sponsors and the PSI scientific committee, for contributing to another fantastic event.
David Lawrence, 2023 PSI Conference Chair
Sarah Williams, 2023 PSI Conference Vice-Chair
Kate Taylor, 2023 PSI Conference Vice-Chair
To access the recorded sessions from the PSI 2023 Conference, please visit our Video on Demand homepage.
To source the Conference content, simply select 'PSI 2023 Conference' from the 'Collection' dropdown menu. This will filter all available content to only show on-demand sessions from the 2023 Conference.
Please note: these are only available to view for Members of PSI, and will need to be signed in to watch them.
A select few of this year's sessions only have the slide decks available. Please see Session Titles listed below, with slide decks available to download beneath.
Please note: these are only accessible for Members of PSI, and you will need to be signed in to access them.
Interactive workshop on communicating data to Data Monitoring Committees
In this interactive workshop, we focused on communicating data to a DMC. The goal of the session was to illustrate difficulties a DMC may have with a report that is not fit for purpose and discuss suggestions for improvements to DMC reports including newer technologies such as apps facilitating an in-depth interrogation of the data. Due to the interactive nature of this session, we wanted to share the slides with members for recapping the session.
HTA & Launch & Life Cycle SIG: Connecting the dots: how can statisticians drive end-to-end thinking in the development of new medicines?
The session began with a lightning round of 5-minute talks from statisticians with different specializations across the lifecycle. These short presentations, where presenters clarify their roles, set the scene. Participants who joined the session then broke out and discussed case studies of “typical new products” intended to help identify and understand the challenges for statisticians from the different perspectives of regulatory, HTA, and medical affairs.
Learning from Mistakes
Experience is the name we give to our mistakes” (Oscar Wilde). Every child falls over before they learn to walk and yet in the workplace there remains fear of making an error. As statisticians, we all understand that even the most stringent processes have a failure rate, but despite this, we often demand perfection from ourselves. Mistakes can range from the trivial through to ones that cost a great deal in time and money. Experienced pharmaceutical statisticians will share some mistakes made and more importantly how to find solutions and share the lessons learnt. Our careers grow from how we respond to problems and challenges. This growth is only possible if organisations create a culture where employees can openly share mistakes and raise concerns; good managers create a healthy environment for staff to thrive and develop, and understand that fear of failure and stress are barriers to progress.
Adaptive Designs - What, why, when and how should I use them
Adaptive designs offer many potential benefits throughout the clinical development process. However, not all of these benefits are accessible all of the time. One must use the right trial design in the right context, which requires careful reflection on the trial’s aim. The intuition about when to use which method presents a barrier to implementation in practice with much of the knowledge locked within the community already practising adaptive designs. In this session, we presented a series of examples and quizzes to help the audience develop their own intuition for adaptive designs. We focussed in particular on group sequential designs that offer the opportunity for early stopping, adaptive designs involving multiple hypothesis tests such as enrichment designs and seamless phase 2-3 designs, and designs that incorporate response adaptive randomisation.
The PSI 2023 Conference took place at Novotel Hammersmith, London between the 11th and 14th of June 2023.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with a choice from two optional half day training course on the Sunday afternoon.
The 2023 PSI conference was record-breaking all round, with 618 delegates listening to more than 120 speakers across 40 sessions! Thank you to everyone involved in the conference: speakers, poster presenters, delegates, exhibitors, sponsors and the PSI scientific committee, for contributing to another fantastic event.
David Lawrence, 2023 PSI Conference Chair
Sarah Williams, 2023 PSI Conference Vice-Chair
Kate Taylor, 2023 PSI Conference Vice-Chair
To access the recorded sessions from the PSI 2023 Conference, please visit our Video on Demand homepage.
To source the Conference content, simply select 'PSI 2023 Conference' from the 'Collection' dropdown menu. This will filter all available content to only show on-demand sessions from the 2023 Conference.
Please note: these are only available to view for Members of PSI, and will need to be signed in to watch them.
A select few of this year's sessions only have the slide decks available. Please see Session Titles listed below, with slide decks available to download beneath.
Please note: these are only accessible for Members of PSI, and you will need to be signed in to access them.
Interactive workshop on communicating data to Data Monitoring Committees
In this interactive workshop, we focused on communicating data to a DMC. The goal of the session was to illustrate difficulties a DMC may have with a report that is not fit for purpose and discuss suggestions for improvements to DMC reports including newer technologies such as apps facilitating an in-depth interrogation of the data. Due to the interactive nature of this session, we wanted to share the slides with members for recapping the session.
HTA & Launch & Life Cycle SIG: Connecting the dots: how can statisticians drive end-to-end thinking in the development of new medicines?
The session began with a lightning round of 5-minute talks from statisticians with different specializations across the lifecycle. These short presentations, where presenters clarify their roles, set the scene. Participants who joined the session then broke out and discussed case studies of “typical new products” intended to help identify and understand the challenges for statisticians from the different perspectives of regulatory, HTA, and medical affairs.
Learning from Mistakes
Experience is the name we give to our mistakes” (Oscar Wilde). Every child falls over before they learn to walk and yet in the workplace there remains fear of making an error. As statisticians, we all understand that even the most stringent processes have a failure rate, but despite this, we often demand perfection from ourselves. Mistakes can range from the trivial through to ones that cost a great deal in time and money. Experienced pharmaceutical statisticians will share some mistakes made and more importantly how to find solutions and share the lessons learnt. Our careers grow from how we respond to problems and challenges. This growth is only possible if organisations create a culture where employees can openly share mistakes and raise concerns; good managers create a healthy environment for staff to thrive and develop, and understand that fear of failure and stress are barriers to progress.
Adaptive Designs - What, why, when and how should I use them
Adaptive designs offer many potential benefits throughout the clinical development process. However, not all of these benefits are accessible all of the time. One must use the right trial design in the right context, which requires careful reflection on the trial’s aim. The intuition about when to use which method presents a barrier to implementation in practice with much of the knowledge locked within the community already practising adaptive designs. In this session, we presented a series of examples and quizzes to help the audience develop their own intuition for adaptive designs. We focussed in particular on group sequential designs that offer the opportunity for early stopping, adaptive designs involving multiple hypothesis tests such as enrichment designs and seamless phase 2-3 designs, and designs that incorporate response adaptive randomisation.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Develop your non-technical skills by reading The Art of Explanation by Ros Atkins and joining the Sept-Dec 2025 book club. You will be invited to join facilitated discussions of the concepts and ideas and apply skills from the book in-between sessions.
Our monthly webinar will allow attendees to gain practical knowledge and skills in Open-Source coding and tools, with a focus on applications in the pharmaceutical industry. The sessions will provide starting points in a number of areas, correct any common misconceptions and provide valuable resources for further learning.
Date: Tuesday 9th September 2025 Join us to hear Sofia Weigle and Weng-Kee Wong present their recent work.
This course is aimed at biostatisticians with no or some pediatric drug development experience who are interested to further their understanding. We will give you an introduction to the pediatric drug development landscape. This will include identifying the key regulations and processes governing pediatric development, a discussion on the needs and challenges when conducting pediatric research and a focus on the ways to overcome these challenges from a statistical perspective.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
AI agents are large language models equipped with tools that can autonomously tackle challenging tasks. This talk will explore how generative AI agents can enable biomedical discovery.
The webinar is targeted at statisticians working in the pharmaceutical industry, and the objective is to 1) provide a basic understanding of IV methodology including how it relates to causal inference, and 2) present two inspirational pharma-relevant applications.
The Pre-Clinical Special Interest Group (SIG) Workshop 2025 will take place over two half-days on 7 - 8 October in Verona, Italy, bringing together experts from industry, academia, and regulatory institutions to discuss key challenges and innovations in pre-clinical research.
Four sessions will include ML foundation (including an introduction, data exploration for ML and dimensionality reduction and feature selection), Supervised learning (including support vector machines and model evaluation and interpretation), model optimization and unsupervised learning (including clustering) and advanced topics (including neural networks, deep learning and large language models).
The program will feature insightful sessions led by distinguished invited speakers, alongside a poster session showcasing the latest advancements in the field. Further details will be provided.
Date: Wednesday 5th November 2025 A careers talk about medical statistics and how it plays a crucial role in developing new medicines
Date: 19 November 2025 This event is aimed at students with an interest in the field of Medical Statistics, for example within pharmaceuticals, healthcare and/or medical research.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
As an Associate Director Biostatistics Early Development, you will be a key member of our biostatistics group, you will play a crucial role in the design, analysis, and interpretation of clinical trials for early development programs.
If you are passionate about biostatistics and real-world data, and are looking for an exciting opportunity to contribute to groundbreaking research, we encourage you to apply.
Are you passionate about making a difference in the world of healthcare? Novartis is seeking a dynamic and experienced professional to join our team in London at The Westworks.
As the Director of HTA Biostatistics & Medical Affairs, you will play a pivotal role in shaping the future of healthcare by providing strategic biostatistical leadership and expertise.
An exciting opportunity has arisen for a permanent Senior Medical Statistician & Statistical Programmer to join the UKCRC fully registered Derby Clinical Trials Support Unit (Derby CTSU).
As a Senior Principal Biostatistician, you will be responsible and accountable for all statistical work, both scientific and operational, for one or more assigned clinical trials
About cookies on this site
We use cookies to collect and analyse information on site performance and usage, to provide social media features and to enhance and customise content and advertisements.
About cookies on this site
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them. When categories than have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. Additionally you can see a list of cookies assigned to each category and detailed information in the cookie declaration.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
CookieHub is a Consent Management Platform (CMP) which allows users to control storage and processing of personal information.
Cloudflare is a global network designed to make everything you connect to the Internet secure, private, fast, and reliable.
Microsoft Azure is a cloud computing platform offering a wide range of services, including virtual machines, databases, and AI tools.
AWS Elastic Load Balancing (ELB) automatically distributes incoming web traffic across multiple servers or services hosted on AWS.
Preferences
Preference cookies enables the web site to remember information to customize how the web site looks or behaves for each user. This may include storing selected currency, region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Google Analytics is a web analytics service offered by Google that tracks and reports website traffic.
Vimeo, Inc. is an American video hosting, sharing, services provider, and broadcaster. Vimeo focuses on the delivery of high-definition video across a range of devices.
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them. When categories than have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. Additionally you can see a list of cookies assigned to each category and detailed information in the cookie declaration.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
| Name | Hostname | Vendor | Expiry |
|---|---|---|---|
| ARRAffinity | .psiweb.org | Session | |
This cookie is set by websites run on the Windows Azure cloud platform. It is used for load balancing to make sure the visitor page requests are routed to the same server in any browsing session. | |||
| ARRAffinitySameSite | .psiweb.org | Session | |
Used to distribute traffic to the website on several servers in order to optimize response times. | |||
| __cf_bm | .vimeo.com | Cloudflare, Inc. | 1 hour |
The __cf_bm cookie supports Cloudflare Bot Management by managing incoming traffic that matches criteria associated with bots. The cookie does not collect any personal data, and any information collected is subject to one-way encryption. | |||
| _cfuvid | .vimeo.com | Cloudflare, Inc. | Session |
Used by Cloudflare WAF to distinguish individual users who share the same IP address and apply rate limits | |||
| __cf_bm | .glueup.com | Cloudflare, Inc. | 1 hour |
The __cf_bm cookie supports Cloudflare Bot Management by managing incoming traffic that matches criteria associated with bots. The cookie does not collect any personal data, and any information collected is subject to one-way encryption. | |||
| AWSALBTGCORS | psi.glueup.com | Amazon Web Services, Inc. | 7 days |
Used by Target Group-based load balancers for session stickiness. | |||
| AWSALBCORS | psi.glueup.com | Amazon Web Services, Inc. | 7 days |
Maintains session stickiness and secure routing between the user and backend servers through AWS load balancing. | |||
| PHPSESSID | psi.glueup.com | Session | |
Cookie generated by applications based on the PHP language. This is a general purpose identifier used to maintain user session variables. It is normally a random generated number, how it is used can be specific to the site, but a good example is maintaining a logged-in status for a user between pages. | |||
| History.store | Session | ||
| cookiehub | .psiweb.org | CookieHub | 365 days |
Used by CookieHub to store information about whether visitors have given or declined the use of cookie categories used on the site. | |||
Preferences
Preference cookies enables the web site to remember information to customize how the web site looks or behaves for each user. This may include storing selected currency, region, language or color theme.
| Name | Hostname | Vendor | Expiry |
|---|---|---|---|
| vuid | .vimeo.com | 400 days | |
These cookies are used by the Vimeo video player on websites. | |||
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
| Name | Hostname | Vendor | Expiry |
|---|---|---|---|
| _ga_ | .psiweb.org | 400 days | |
Contains a unique identifier used by Google Analytics 4 to determine that two distinct hits belong to the same user across browsing sessions. | |||
| _ga | .psiweb.org | 400 days | |
Contains a unique identifier used by Google Analytics to determine that two distinct hits belong to the same user across browsing sessions. | |||
